Journal article
Structure-based Design of Peptides with High Affinity and Specificity to HER2 Positive Tumors
- Abstract:
- To identify peptides with high affinity and specificity against human epidermal growth factor receptor 2 (HER2), a series of peptides were designed based on the structure of HER2 and its Z(HER2:342) affibody. By using a combination protocol of molecular dynamics modeling, MM/GBSA binding free energy calculations, and binding free energy decomposition analysis, two novel peptides with 27 residues, pep27 and pep27-24M, were successfully obtained. Immunocytochemistry and flow cytometry analysis verified that both peptides can specifically bind to the extracellular domain of HER2 protein at cellular level. The Surface Plasmon Resonance imaging (SPRi) analysis showed that dissociation constants (K D) of these two peptides were around 300 nmol/L. Furthermore, fluorescence imaging of peptides against nude mice xenografted with SKBR3 cells indicated that both peptides have strong affinity and high specificity to HER2 positive tumors.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.6MB, Terms of use)
-
- Publisher copy:
- 10.7150/thno.12398
Authors
- Publisher:
- Ivyspring International Publisher
- Journal:
- Theranostics More from this journal
- Volume:
- 5
- Issue:
- 10
- Pages:
- 1154-1165
- Publication date:
- 2015-08-01
- DOI:
- EISSN:
-
1838-7640
- ISSN:
-
1838-7640
- Language:
-
English
- Keywords:
- Pubs id:
-
1268752
- Local pid:
-
pubs:1268752
- Source identifiers:
-
W1506057118
- Deposit date:
-
2025-11-20
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2015
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record